Our Litigation Advantage Reports
for patent litigation analysis:

• Understand critical issues of value that underly complex patent litigation

• Obtain unprecedented equity research covering pharmaceutical, semiconductor, medical device and biotech stocks

• Form investment strategies by anticipating quantifiable judgements, responses

• Forecast the workarounds, alliances and acquisitions that companies in patent disputes will develop

“Although the jury verdict surprised many analysts, intellectual property consultancy Perception Partners wasn’t among them.”

-Medical Device Link Magazine

 

LITIGATION ADVANTAGE™ REPORTS PREDICT OUTCOMES, SIMPLIFY COMPLEXITIES IN PATENT INFRINGEMENT LITIGATION

In-depth, highly visual litigation assessment
World-class scientific, legal and valuation predictions
Full coverage of stock impact over life of a case

Litigation Advantage Reports – designed with institutional investors in mind – cover patent litigation risk in select high-tech, pharmaceutical, medical device and biotechnology cases. Reports contain technical and business assessments related to patent validity, enforceability or infringement. In addition, reports heavily utilize visual aids to simplify the complex series of events that comprise a litigation to improve valuation assessment of the litigants in the cases.

Reports are provided on a subscription basis and cover various aspects of patent litigation and its impacts on stakeholders.

Reports offer:

• High level projections of likely winners. losers and impact in plain English

• Five “Deep Dive” exhibit decks consisting of about 10 – 30 slides. Deep Dive analysis may contain original investigation, global technical analysis, executive interviews or advanced competitive intelligence. Some Deep Dives are custom to each client and those have an exclusivity period attached.

• Seven “Quick Look” narrative documents with about of about 3 – 5 supporting exhibits. Quick Looks overview or update a specific litigation, and provide summary-level recommendations. Quick Looks are typically used to introduce a case or augment other information..

• Deliverables provided electronically as password-protected PDF files

• A Perception Partners representative will be available to present each Rreport and to answer any questions. Personal consultations regarding report subject matter are also available when appropriate.

SAMPLE FOR DOWNLOAD! KINETIC CONCEPTS VS. BLUESKY INVESTOR ADVANTAGE™ REPORT

Visual evidence that undermines a billion-dollar patent position for KCI. Select institutional and private equity investors made millions from this information.

This Report definitively illustrates the challenges faced in this contentious trial with:

* A visual timeline of prior art and issues of obviousness
* Translated articles from Russia (beyond what BlueSky has published)
* Claims charts for all independent claims at issue
* A discussion of options for investors

Consider Perception Partners for help assessing your high tech, biotech, pharmaceutical, manufacturing, and consumer products investments. Contact us now to get a free copy of the KCI vs. BlueSky Investor Advantage™ Report.